- Home
- DKI vs EDSA Comparison
DKI vs EDSA Comparison
Compare DKI & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DKI
- EDSA
- Stock Information
- Founded
- DKI 2018
- EDSA 2015
- Country
- DKI Hong Kong
- EDSA Canada
- Employees
- DKI N/A
- EDSA N/A
- Industry
- DKI
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- DKI
- EDSA Health Care
- Exchange
- DKI Nasdaq
- EDSA Nasdaq
- Market Cap
- DKI 11.9M
- EDSA 12.8M
- IPO Year
- DKI 2025
- EDSA N/A
- Fundamental
- Price
- DKI $0.45
- EDSA $1.75
- Analyst Decision
- DKI
- EDSA Strong Buy
- Analyst Count
- DKI 0
- EDSA 2
- Target Price
- DKI N/A
- EDSA $13.00
- AVG Volume (30 Days)
- DKI 220.8K
- EDSA 911.0K
- Earning Date
- DKI 11-28-2025
- EDSA 12-12-2025
- Dividend Yield
- DKI N/A
- EDSA N/A
- EPS Growth
- DKI N/A
- EDSA N/A
- EPS
- DKI 26.19
- EDSA N/A
- Revenue
- DKI $10,204,329.00
- EDSA N/A
- Revenue This Year
- DKI N/A
- EDSA N/A
- Revenue Next Year
- DKI N/A
- EDSA N/A
- P/E Ratio
- DKI $0.02
- EDSA N/A
- Revenue Growth
- DKI 100.46
- EDSA N/A
- 52 Week Low
- DKI $0.43
- EDSA $1.55
- 52 Week High
- DKI $15.00
- EDSA $4.49
- Technical
- Relative Strength Index (RSI)
- DKI N/A
- EDSA 33.55
- Support Level
- DKI N/A
- EDSA $1.68
- Resistance Level
- DKI N/A
- EDSA $1.83
- Average True Range (ATR)
- DKI 0.00
- EDSA 0.13
- MACD
- DKI 0.00
- EDSA -0.01
- Stochastic Oscillator
- DKI 0.00
- EDSA 13.21
About DKI DarkIris Inc. Class A Ordinary Shares
Darkiris Inc is a comprehensive technology enterprise engaged in the development, publishing and operating of mobile digital games via various third-party digital storefronts. Its activities encompass including game design, programming and graphics, as well as distribution and operation of mobile games on various platforms. Its core product offerings are Games Development; develop, market and distribute its self-developed mobile games; and Games Publishing and Operation. It publish and operate its self-developed mobile games and mobile games it license from other game developers.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.